Literature DB >> 6325237

Heparin inhibits the activity of protein phosphatase-1.

P Gergely, F Erdödi, G Bot.   

Abstract

Heparin inhibited the dephosphorylation of rabbit skeletal muscle or liver phosphorylase a by protein phosphatase-1. Other glycosaminoglycans (chondroitin sulfates) and their constituents were found to be without effect. The chromatography of a partially purified phosphatase preparation on heparin-Sepharose CL-6B resulted in a fraction that did not bind to the matrix and its activity was not inhibited by heparin or inhibitor-1. The phosphatase bound to heparin-Sepharose was eluted by 0.2 M NaCl and was inhibited by heparin or inhibitor-1.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325237     DOI: 10.1016/0014-5793(84)80286-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).

Authors:  Mark R Swingle; Richard E Honkanen
Journal:  Assay Drug Dev Technol       Date:  2014-10       Impact factor: 1.738

2.  Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate.

Authors:  U Zor; E Ferber; P Gergely; K Szücs; V Dombrádi; R Goldman
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

3.  Exocytosis induction in Paramecium tetraurelia cells by exogenous phosphoprotein phosphatase in vivo and in vitro: possible involvement of calcineurin in exocytotic membrane fusion.

Authors:  M Momayezi; C J Lumpert; H Kersken; U Gras; H Plattner; M H Krinks; C B Klee
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

4.  Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.

Authors:  Alessandro Russo; Francesca Gavaruzzi; Giancarlo Ceccarelli; Cristian Borrazzo; Alessandra Oliva; Francesco Alessandri; Eugenia Magnanimi; Francesco Pugliese; Mario Venditti
Journal:  Infection       Date:  2021-06-27       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.